2015;65(16):1619-1629. 286. Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial brillation undergoing PCI. N Engl J Med. 2016;375(25):2423-2434. 287. Gibson CM, Pinto DS, Chi G, et al. Recurrent hospitalization among patients with atrial brillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral vitamin K antagonist treatment strategy. Circulation. 2017;135(4):323-333. 288. Cannon CP, Bhatt DL, Oldgren J, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial brillation. N Engl J Med. 2017;377(16):1513-1524. 289. Sarafoff N, Martischnig A, Wealer J, et al. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug- eluting stent implantation and an indication for oral anticoagulation. J Am Coll Cardiol. 2013;61(20):2060-2066. 290. Ohman EM, Roe MT, Steg PG, et al. Clinically signi cant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet. 2017. 291. Nielsen PB, Skjoth F, Rasmussen LH, Larsen TB, Lip GY. Using the CHA2DS2-VASc score for stroke prevention in atrial brillation: a focus on vascular disease, women, and simple practical application. Can J Cardiol. 2015;31(6):820.e9-820.e10. 292. Lin LY, Lee CH, Yu CC, et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial brillation a nation wide database analysis. Atherosclerosis. 2011;217(1):292-295. 293. Lamberts M, Gislason GH, Lip GY, et al. Antiplatelet therapy for stable coronary artery disease in atrial brillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation. 2014;129(15):1577-1585. 294. Kumar S, Danik SB, Altman RK, et al. Non-vitamin K antagonist oral anticoagulants and antiplatelet therapy for stroke prevention in patients with atrial brillation: a meta-analysis of randomized controlled trials. Cardiol Rev. 2016;24(5):218-223. 295. Dans AL, Connolly SJ, Wallentin L, et al. 